1. Home
  2. AVR vs EPSN Comparison

AVR vs EPSN Comparison

Compare AVR & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVR
  • EPSN
  • Stock Information
  • Founded
  • AVR 1999
  • EPSN 2005
  • Country
  • AVR Australia
  • EPSN Canada
  • Employees
  • AVR N/A
  • EPSN N/A
  • Industry
  • AVR
  • EPSN Oil & Gas Production
  • Sector
  • AVR
  • EPSN Energy
  • Exchange
  • AVR NYSE
  • EPSN Nasdaq
  • Market Cap
  • AVR 162.1M
  • EPSN 175.3M
  • IPO Year
  • AVR 2024
  • EPSN N/A
  • Fundamental
  • Price
  • AVR $3.33
  • EPSN $6.23
  • Analyst Decision
  • AVR Strong Buy
  • EPSN Strong Buy
  • Analyst Count
  • AVR 4
  • EPSN 1
  • Target Price
  • AVR $16.50
  • EPSN $7.00
  • AVG Volume (30 Days)
  • AVR 202.3K
  • EPSN 128.8K
  • Earning Date
  • AVR 08-16-2025
  • EPSN 08-13-2025
  • Dividend Yield
  • AVR N/A
  • EPSN 4.01%
  • EPS Growth
  • AVR N/A
  • EPSN N/A
  • EPS
  • AVR N/A
  • EPSN 0.20
  • Revenue
  • AVR $2,493,000.00
  • EPSN $39,699,172.00
  • Revenue This Year
  • AVR $33.26
  • EPSN $41.35
  • Revenue Next Year
  • AVR $194.42
  • EPSN N/A
  • P/E Ratio
  • AVR N/A
  • EPSN $31.79
  • Revenue Growth
  • AVR N/A
  • EPSN 35.21
  • 52 Week Low
  • AVR $2.34
  • EPSN $4.95
  • 52 Week High
  • AVR $8.79
  • EPSN $8.50
  • Technical
  • Relative Strength Index (RSI)
  • AVR N/A
  • EPSN 32.76
  • Support Level
  • AVR N/A
  • EPSN $6.14
  • Resistance Level
  • AVR N/A
  • EPSN $6.41
  • Average True Range (ATR)
  • AVR 0.00
  • EPSN 0.24
  • MACD
  • AVR 0.00
  • EPSN -0.04
  • Stochastic Oscillator
  • AVR 0.00
  • EPSN 7.56

About AVR ANTERIS TECHNOLOGIES GLOBAL CORP

Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

About EPSN Epsilon Energy Ltd. Common Share

Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.

Share on Social Networks: